DEVELOPMENT OF INTRAVENOUS ADMINISTRATION OF L-LYSINE-ALPHA-OXIDASE FROM TRICHODERMA CF. AUREOVIRIDE RIFAI BKMF-4268 REGIME CONTROLLED BY SAFETY AND EFFICACY OF TREATMENT ArticlePokrovsky V.S., Treshalina E.M., Lukasheva E.V., Sedakova L.A.Российский онкологический журнал. 2013. P.. 10-14
EFFICACY OF ADRIAMYCIN+CYCLIPHOSPHAMIDE (АС) REGIME OF NEOADJUVANT CHEMOTHERAPY IN COMBINATION WITH BICATALYTIC SYSTEM TERAPHTAL + ASCORBIC ACID BY THE TREATMENT ON MURINE BREAST CANCER CA-755 ArticleKalishyan M.S., Sedakova L.A., Raichlin H.T., Treshalina H.M., Lukasheva E.V.Российский биотерапевтический журнал. Vol. 8. 2009. P.. 51-56
THE SEARCH OF THE NEW ANTITUMOR ENZYMES ArticleLukasheva E.V., Lebedeva Z.I., Keramova A.H., Treshalina E.M., Sedakova L.A.Вестник Российского университета дружбы народов. Серия: Медицина. 2006. P.. 42-46
BIOLOGICAL PROPERTIES OF L-LYSINE A-OXIDASE IN NATIVE AND CONJUGATED FORM ArticleTreshalina H.M., Zhukova O.S., Lukasheva E.V., Sedakova L.A., Andronova N.V., Solntzeva T.I., Gogichaeva N.V., Berezov T.T.Биомедицинская химия. Vol. 50. 2004. P.. 376-383